Gros David-Alexandre C 4
4 · Eledon Pharmaceuticals, Inc. · Filed Nov 22, 2024
Insider Transaction Report
Form 4
Gros David-Alexandre C
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2024-11-21+1,015,743→ 1,015,743 totalExercise: $2.30Exp: 2033-05-01→ Common Stock (1,015,743 underlying)
Footnotes (1)
- [F1]This transaction represents the attainment of the performance conditions applicable to an option award subject to both performance-based and time-based vesting criteria granted to the reporting person on May 1, 2023. The option was determined to satisfy the performance-based vesting criteria with respect to 1,015,743 shares of underlying Common Stock on November 21, 2024 and time-based vesting criteria with respect to 380,904 shares of underlying Common Stock on November 1, 2024. The option will satisfy the time-based vesting criteria with respect to the 634,839 remaining shares of Common Stock underlying the option in substantially equal quarterly installments over a three-year period ending May 1, 2027.